Weight loss from diets, surgery, and GLP-1 drugs all increase bone loss, but GLP-1 medications may have some bone-protective properties at high doses.
Mixed signalsGLP-1 drugs show bone protection in animals at high doses but accelerated bone loss in humans during weight loss
What the researchers found
All weight-loss interventions increase bone turnover; bariatric surgery is worst for bone health. GLP-1 drugs show mixed signals—protective in animals at high doses but potentially harmful during significant human weight loss.
Why it matters
With millions of people using GLP-1 drugs for weight loss, understanding bone safety is critical, especially for patients already at fracture risk.
The numbers in context
- No specific statistical results reported
- Two RCTs have tested anti-osteoporosis medications post-bariatric surgery
- Animal studies used liraglutide doses higher than human-approved doses
- Multiple mechanisms identified for post-surgical bone loss
How the study worked
Narrative review of preclinical and clinical evidence on bone effects of calorie restriction, bariatric surgery, and GLP-1 receptor agonists.
Who was studied
Narrative review covering people with obesity undergoing calorie restriction, bariatric surgery, or GLP-1 receptor agonist treatment.
What this study cannot tell us
Narrative review with heterogeneous study types. Animal dose levels far exceed human therapeutic doses. Long-term human fracture data are limited.
How to read the evidence
Narrative review integrating preclinical and clinical data. Moderate evidence quality; gaps in long-term human data.
When this study was published
Published in 2025.
The bigger picture
As incretin-based weight loss becomes widespread, bone health monitoring and protective strategies should become standard components of obesity management.
Questions still open
- Should bone density screening be routine for patients on long-term GLP-1 therapy?
- Can concurrent exercise or supplements mitigate bone loss during GLP-1 weight loss?
Common questions
Do GLP-1 weight-loss drugs weaken bones?
Should I get my bones checked while on semaglutide?
Read the original research
Effects of weight-loss interventions on bone health in people living with obesity.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 40(12), 1319-1331
Citation
Paccou, Julien; Gagnon, Claudia; Yu, Elaine W; Rosen, Clifford J. (2025). Effects of weight-loss interventions on bone health in people living with obesity.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 40(12), 1319-1331. https://doi.org/10.1093/jbmr/zjaf135